GlassScriptPhysician profile
Frank W Bell
NPI 1578670402
$7,971.62
in general payments reported to CMS, 2019-2025
23 companies · $494 in 2025
The $494 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,661 · 2020: $2,291 · 2021: $635 · 2022: $444 · 2023: $989 · 2024: $458 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,940.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $2,654.16 | 2019-2025 | Puraply, Affinity, Apligraf |
| Integra Lifesciences Corporation | $2,080.05 | 2020-2025 | Tcc-Ez |
| Smith+Nephew, INC. | $1,029.36 | 2019-2025 | Collagenase Santyl, Grafix, Grafix Pl |
| Kci USA, INC. | $478.44 | 2019-2022 | |
| Next Science LLC | $378.02 | 2022-2024 | Xperience, Blastx, Surgx |
| Viiv Healthcare Company | $232.83 | 2019 | |
| Kerecis Limited | $203.94 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Osiris Therapeutics INC. | $192.24 | 2019 | |
| Gilead Sciences, INC. | $121.11 | 2023 | |
| Medline Industries LP | $88.55 | 2019-2024 | |
| Inari Medical, INC. | $74.46 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Hartmann USA, INC. | $74.14 | 2025 | Zetuvit Plus 10x10 P10 |
| Mimedx Group, INC. | $65.77 | 2024-2025 | |
| Abbvie INC. | $61.27 | 2023-2024 | Dalvance |
| Acera Surgical, INC. | $53.35 | 2024 | Restrata Wound Matrix |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $39.99 | 2024-2025 | Activ.A.C., V.A.C. Granufoam, 3m Cavilon |
| Convatec INC. | $33.55 | 2019 | |
| Paratek Pharmaceuticals, INC. | $30.84 | 2025 | Nuzyra |
| Ibsa Pharma INC. | $19.38 | 2022 | |
| Hydrofera LLC | $19.01 | 2022 | |
| Melinta Therapeutics, LLC | $14.54 | 2019 | |
| Boston Scientific Corporation | $14.31 | 2025 | Watchman Flx |
| Reprise Biomedical, INC. | $12.31 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.